Teva launches Rajani, its Beyaz generic

JERUSALEM — Teva on Wednesday announced the U.S. launch of its Rajani (drospirenone, ethinyl estradiol and levomefolate calcium tablets 3 mg/0.02 mg/0.451 mg and levomefolate calcium tablets 0.451 mg), a generic of oral contraceptive Beyaz. 

 

Teva’s Rajani will be available in 28-day blister packs. The drug had $133 million in U.S. sales for the 12 months ended July 2016, according to IMS Health.